Institutional Biosafety Committee (IBC)
New NIH “Dangerous Gain-of-Function” Research Requirements (6/24/2025)
The National Institutes of Health (NIH) has issued new requirements for notification, suspension, or termination of “dangerous gain-of-function research.” Please see the news post linked above for more information.
Overview
In order to ensure all biosafety spaces are inspected and that the Institutional Biosafety Committee (IBC) has a record of all biosafety work being conducted on campus, IBC registration is required for all labs (research and/or educational) using biological materials of any kind.
IBC protocol approval is required prior to the use of biohazards in research or teaching. Under 91±¬ÁĎ policy, “biohazard” includes recombinant or synthetic nucleic acid molecules (including plants), biological materials/biospecimens (human and animal blood, bodily fluids, and/or tissues), infectious agents*, or select agents/toxins. (*The 91±¬ÁĎ has defined “infectious agents” as all bacterial, parasitic, fungal, viral, and prion, included within Class 2 or higher classes; see Appendix B of .)
For guidance on whether your biohazards work requires IBC or other approvals, view the IBC Registration and Protocol Submission Flow Chart: Diagram IBC Flow Chart (Word);ĚýPlain Text IBC Flow Chart (Word).
Questions regarding the IBC may be directed to umric@maine.edu.
Up Next: Policy
Contact for IBC Questions

Andrew Holmes, Ph.D.
Institutional Biosafety Officer
andrew.p.holmes@maine.edu
207.581.3827

Amanda Ashe, CRA, ECoP®– EAR/ITAR
Director of Research Compliance, Export Control Officer
amanda.l.ashe@maine.edu
207.581.1480, 310 Alumni Hall

Paula Portalatin, CIP, CPIA
Associate Director of Research Compliance
paula.portalatin@maine.edu
207.581.2657, 311 Alumni Hall
